Corporate information
Registration country
Company type
Developer of the innovative class of drug substance (curaxins) for oncological and autoimmune treatment diseasesFunding rounds
N/A
( )
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Bioprocess Capital Ventures | USD 18,000,000 (USD 18,000,000) | ||
|
|
Cleveland BioLabs Inc |
Investment activity status
Active investor